PATENT CLAIM ANALYSIS

Application Number: 16069046
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "210180"]

Abstract:
The present invention encompasses compounds of the formula (I) wherein the groups R1, R2, R3, R4 and R5 are defined herein, which are suitable for the treatment of diseases related to Bruton's tyrosine kinase (BTK), and processes for making these compounds, pharmaceutical preparations containing these compounds, and their methods of use.

Claim (Index 4):
The compound of the formula (I) according to  claim 1 , wherein R 1  is chosen from wherein R 6  is H or CH 3  and; R 2  is CH 2 OH; R 3  is chosen from; wherein Y is R 4  is chosen from H or F each R 5  is independently chosen from H, C 1-4  alkyl, or C 3-4  cycloalkyl; each group defined above for R 1 -R 5  is, where possible, partially or fully halogentated.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 95.0
- Lexical Diversity: 1.42222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15379745', '15861688', '14670425', '15257926', '14670421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683036250212553
- 35 USC 102 Novelty (BERT): 0.5191847920214769
- Combined Prediction Score: 0.7433917417212774
- Mean Citation Score: 292.902504
- Max Citation Score: 307.41968
- Similarity Product: 256.8350706702042

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test